INHIBITION OF AXL SIGNALING IN ANTI-METASTATIC THERAPY

Compositions and methods are provided for alleviating cancer in a mammal by administering a therapeutic dose of a pharmaceutical composition that inhibits activity of AXL protein activity, for example by competitive or non-competitive inhibition of the binding interaction between AXL and its ligand...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: FUH, KATHERINE, RANKIN, ERINN BRUNO, MIAO, YU, KARIOLIS, MIHALIS, GIACCIA, AMATO J, JONES, DOUGLAS, COCHRAN, JENNIFER R
Format: Patent
Sprache:eng ; fre
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Compositions and methods are provided for alleviating cancer in a mammal by administering a therapeutic dose of a pharmaceutical composition that inhibits activity of AXL protein activity, for example by competitive or non-competitive inhibition of the binding interaction between AXL and its ligand GAS6. La présente invention concerne des compositions et des procédés pour atténuer un cancer chez un mammifère par administration d'une dose thérapeutique d'une composition pharmaceutique qui inhibe l'activité de la protéine AXL, par exemple par inhibition compétitive ou non compétitive de l'interaction de liaison entre AXL et son ligand GAS6.